The healthcare investment platform provider Lian Group, situated in Luxembourg,Israel has purchased Scientis, a cosmeceutical company based in Geneva, Switzerland. The deal’s total value was not made public.
Lian’s presence in the healthcare sector is reinforced and broadened by this acquisition, as the company concentrates on funding the establishment of businesses that provide solutions that adapt to changing market demands.
Dermatology firm Scientis is committed to treating skin pigmentation. Its main product, Cyspera®, is a clinically validated pigment corrector called Cysteamine Isobionic-Amide ComplexTM.
Cyspera is positioned as a topical medication to utilize its antioxidant-rich mix to treat discolouration and uneven skin tone. Building on an established position in Asia and the US, the company is prepared to enter worldwide markets.
Read also- Singapore-Based Protos Labs has Secured $2.3 Million in Oversubscribed Seed Round Funding
Under the direction of Managing Partner Fiorenzo Manganiello, Lian Group is an investment organization that funds and builds businesses in close partnership with business owners. It creates value through investing capital and knowledge, concentrating on healthcare possibilities, digital assets, and infrastructure.
Read also- Austraila-Based Trianz Strategic Collaboration Agreement with AWS
“We are thrilled to welcome Scientis to LIAN Group’s healthcare platform. With our hands-on approach, we are committed to accelerating Scientis’ growth and sales in new markets. We will support management by leveraging our network, expertise and resources to expand into new markets, streamline operations, develop innovative products and services, and empower patients and healthcare professionals with high-quality solutions.” says Fiorenzo Manganiello, Managing Partner of LIAN Group.
About Lian Group
LIAN Group, a specialized investment organization, works with prominent entrepreneurs to establish and fund successful firms in the most important areas.
About Scientis
Scientis is a Swiss dermatology company. Developing and presenting innovative dermo-cosmetic treatments to patients for skin pigmentation issues is mission. The top product is Cyspera®. To treat the appearance of discolouration and dark spots, Cyspera® is the first pigment corrector manufactured with cysteamine.
